Updated on 21 June 2016
Singaore: In a press statement released today by ResMed, the company has announced that Brightree has made new appointments to its management team. It has to be recalled that ResMed acquired Brightree in April 2016.
Brightree has appointed Matt Mellott as the new CEO and Bobby Ghoshal as the new COO.
"Matt Mellott and Bobby Ghoshal join an exceptional senior leadership team with a commitment to customer-centered innovation and a culture of excellence. They will continue moving Brightree forward, expanding on the company's leadership in business management and clinical software applications for the post-acute care industry," said President of Healthcare Informatics Raj Sodhi.
"Brightree wouldn't be the company it is today without the leadership of Dave Cormack, whose tenure as president and CEO began in 2005. We're pleased Dave has agreed to stay on in an advisory role to ensure a smooth transition, added Sodhi.
"ResMed and Brightree will continue to shape the frontier of digital health. Their innovations in software, informatics and devices will continue to improve patients' quality of life, slow the progression of chronic diseases and lower overall healthcare system costs while enabling HMEs and other post-acute care providers to better manage their businesses and optimize patient care," said Sodhi.